期刊文献+

VEGF对人血单核细胞TIMPs表达的影响 被引量:1

Effect of VEGF on Expression of TIMPs in Human Monocytes
下载PDF
导出
摘要 目的 探讨血管内皮生长因子(VEGF)对人单核细胞源巨噬细胞(HMDM)组织基质金属蛋白酶抑制物(TIMPs)的基因和蛋白表达的影响。 方法 分别应用RT-PCR和Western blot检测TIMP(TIMP-1和TIMP-2)基因和蛋白表达。结果 VEGF可明显抑制HMDM TIMP-1 mRNA、TIMP-2 mRNA及其蛋白表达。 结论 VEGF可抑制HMDM TIMP-1 mRNA、TIMP-2 mRNA及其蛋白的表达,可能间接增强基质金属蛋白酶(MMPs)活性,因而有可能促进动脉粥样硬化斑块内基质降解,进而引起粥样硬化斑块破裂。 Objective To observe the effect of VEGF on the expressions of tissue inhibitors of metalloproteinase (TIMPs). Methods The gene and protein expressions of TIMPs (TIMP-1 and TIMP - 2) were respectively detected by RT - PCR and Western blot. Results VEGF can obviously decrease the expressions of TIMP - 1 and TIMP - 2 in human monocytes. Conclusion VEGF can decrease the expressions of TIMP - 1 and TIMP - 2 in human monocytes, may be helpful to promote the breakdown of the matrix in the atherosclerotic lesions and enhance their vulnerability.
出处 《上海第二医科大学学报》 CSCD 2003年第3期200-202,209,共4页 Acta Universitatis Medicinalis Secondae Shanghai
基金 上海市青年科技启明星计划资助项目(98QB14014)
关键词 血管内皮生长因子 单核细胞 巨噬细胞 组织基质金属蛋白酶抑制物 动脉粥样硬化 细胞培养 vascular endothelial growth factor tissue inhibitors of metalloproteinase atherosclerosis
  • 相关文献

参考文献13

  • 1Xu XP, Meisel SR, Ong JM, et al. Oxidized low-density lipoprotein regulates matrix metalloproteinae-9 and its tissue inhibitor in human monocyte-derived macrophages [J]. Circulation, 1999, 99: 993-998.
  • 2Wang H, Keiser JA. Vascular endothelial growth factor upregulates the expression of matrix metalloproteinases in vascular smooth cells: role of flt-1 [J]. Circ Res, 1998, 83: 832-840.
  • 3Galis ZS, Sukhova GK, Lark MW, et al. Increase expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques [J]. J Clin Invest, 1994, 94: 2493-2503.
  • 4Inoue M, Itoh H, Ueda M, et al. Vascular endothelial growth factor (VEGF) expression in human coronary atherosclerotic lesions: possible pathophysiological significance of VEGF in progression of athe rosclerosis [J]. Circulation, 1998, 98: 2108-2116.
  • 5Cuici JA, Mao DL, Bohner DG, et al. Preoperative treatment with doxycycline reduces aortic wall expression and activation of matrix metalloproteinases in patients with abdominal aortic aneurysms[J]. J Vasc Surg, 2000, 31: 325-342.
  • 6Grant GM, Cobb JK, Castillo B, et al. Regulation of matrix metalloproteinases follows cellular transformation [J]. J Cell Physiol, 1996, 167 (1): 177-183.
  • 7Falk E, Shah PK, Fuster V. Coronary plaque disruption [J]. Circulation, 1995, 92: 657-667.
  • 8Galis ZS, Sukhova GK, Libby P. Microscopic localization of active proteinases by in situ zymography: detection of matrix metalloproteinase activity in vascular tissue[J]. FASEB J, 1995, 9: 974-980.
  • 9Murphy G, Willenbrock F, Crabbe T, et al. Regulation of matrix metalloproteinase activity[J]. Ann N Y Acad Sci, 1994, 732: 31-41.
  • 10Moreau M, Brocheriou I, Petit L, et al. Interleukin-8 mediates downregulation of tissue inhibitor of metalloproteinase-1 expression in cholesterol-loaded human macrophages: relevance to stability of atherosclerotic plaque[J]. Circulation, 1999, 99: 420-426.

同被引文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部